Vivosim Labs Inc share price logo

Vivosim Labs Inc Share Price

NASDAQ: VIVS

Small Cap

$4.16

+0.47

(+12.65%)

as on

Vivosim Labs Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $3.7
    $4.22
    downward going graph

    11.06%

    Downside

    1.44%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.41
    $4.22
    downward going graph

    66.11%

    Downside

    1.44%

    Upside

    downward going graph

Vivosim Labs Inc share price movements today

Previous Close
$3.69
Open
$3.72
Volume
969.7K
Day's Low - High
$3.7 - $4.22
52 Week Low - High
$1.41 - $4.22

Vivosim Labs Inc Historical Returns

1 Month Return
+ 125.27 %
3 Month Return
+ 160.25 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Vivosim Labs Inc Stock Fundamentals & Key Indicators

Check Vivosim Labs Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.1M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

13900900.00%

Vivosim Labs Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vivosim Labs Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Vivosim Labs Inc image
Vivosim Labs Inc
NA$5.1MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B280.5%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$37.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.2B54.04%28.0831.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.4B2.03%14.1131.37%

Vivosim Labs Inc Stock's Interest Amongst Investors

Search interest for Vivosim Labs Inc Stock has increased by 58% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:58% versus previous 30 day period

Vivosim Labs Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-7
-4
-3
-3
-3
-2
-3
-3
-2
EBITDA
-7
-4
-3
-3
-3
-2
-3
6
-2
Interest Expense
-
-
-
-
-
-
0
0
0
Depreciation
-
-
0
0
0
0
0
0
0
Income Before Tax
-7
-4
-3
-3
-3
-2
-3
6
-2
Income Tax Expense
-
0
-
-
0
-
-
-
-
Net Income
-7
-4
-3
-3
-3
-2
-3
6
-2
Net Profit Margin
-4604.32%
-5370.67%
-72080.00%
-10500.00%
-8574.36%
-8496.67%
-14362.50%
13435.29%
-7683.78%

Vivosim Labs Inc Annual Profit & Loss

All numbers in Millions USD

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
1
4
4
3
2
-
1
0
0
0
Gross Profit
1
3
3
2
1
-
1
0
0
0
Operating Income
-38
-38
-35
-27
-21
-16
-11
-17
-15
-12
EBITDA
-37
-37
-34
-26
-20
-16
-11
-17
-14
-2
Interest Expense
-
-
-
-
-
-
-
-
-
0
Depreciation
-
-
-
-
-
0
0
0
0
0
Income Before Tax
-38
-38
-34
-26
-18
-16
-11
-17
-14
-2
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-38
-38
-34
-26
-18
-16
-11
-17
-14
-2
Net Profit Margin
-2601.15%
-908.91%
-756.09%
-861.70%
-852.00%
0.00%
-763.20%
-4664.59%
-13459.63%
-1727.78%

Vivosim Labs Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-4
-3
-3
-3
-3
-2
-3
6
-2
Operating Cash Flow
-5
-3
-3
-2
-2
-2
-1
-2
-3
Investing Cash Flow
0
0
0
0
0
-
0
9
-
Financing Cash Flow
-
-
1
0
6
0
0
3
1
Change in Cash
-4
-3
-2
-2
3
-3
-2
10
-2

Vivosim Labs Inc Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
-38
-34
-26
-18
-16
-11
-17
-14
-2
Operating Cash Flow
-29
-28
-20
-14
-13
-8
-12
-14
-9
Investing Cash Flow
-1
0
0
0
0
0
0
0
9
Financing Cash Flow
31
10
13
4
23
0
-
1
8
Change in Cash
0
-19
-7
-9
10
-8
-13
-12
8

Insights on Vivosim Labs Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, VIVS stock has moved up by 67.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 208.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 111.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 6.85M → -2.84M (in $), with an average decrease of 141.5% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 51.0K → 37.0K (in $), with an average decrease of 27.5% per quarter

About Vivosim Labs Inc

VivoSim Labs, Inc. is a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. The Company offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The Company offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. It uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The Company's 3D human tissue platform is multifaceted. The Company has expertise in 3D organoids, such as spheroids, and has made advances in proprietary cell culture techniques including ratios, components and conditions.
OrganisationVivosim Labs Inc
Headquarters11555 Sorrento Valley Road, San Diego, CA, United States, 92121
CEOMr. Keith E. Murphy
E-voting on sharesClick here to vote

Key Management of Vivosim Labs Inc

Name

Title

Mr. Tony Lialin

Chief Commercial Officer

Mr. Keith E. Murphy

Executive Chairman & Corporate Secretary

Mr. Norman Staskey

President, CFO & Principal Financial Officer

Dr. Curtis M. Tyree Ph.D.

Senior Vice President of Strategy & Business Development

FAQs

What is Vivosim Labs Inc share price today?

Vivosim Labs Inc share price today is $4.16 as on at the close of the market. Vivosim Labs Inc share today touched a day high of $4.22 and a low of $3.7.

What is the 52 week high and 52 week low for Vivosim Labs Inc share?

Vivosim Labs Inc share touched a 52 week high of $4.22 on and a 52 week low of $1.41 on . Vivosim Labs Inc stock price today i.e. is closed at $4.16,which is 1.42% down from its 52 week high and 195.04% up from its 52 week low.

What is Vivosim Labs Inc's market capitalisation today?

Vivosim Labs Inc market capitalisation is $0.00T as on .

How to invest in Vivosim Labs Inc Stock (VIVS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vivosim Labs Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vivosim Labs Inc Shares that will get you 0.3606 shares as per Vivosim Labs Inc share price of $4.16 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Vivosim Labs Inc Stock (VIVS) from India?

Indian investors can start investing in Vivosim Labs Inc (VIVS) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Vivosim Labs Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Vivosim Labs Inc share’s latest price of $4.16 as on September 13, 2025 at 1:29 am IST, you will get 2.4038 shares of Vivosim Labs Inc. Learn more about fractional shares .